Effects of insulin initiation on patient-reported outcomes in patients with type 2 diabetes: Results from the DURABLE trial
Lauren J. Lee(Eli Lilly (United States)), Ruth S. Weinstock(SUNY Upstate Medical University), Lori McLeod(RTI International), Jessie L. Fahrbach(Eli Lilly (United States)), Lauren Nelson(RTI Health Solutions), Peter P. Sun(UCSF Benioff Children's Hospital), Sherry Martin(Eli Lilly (United States))
Cited by 11
Related Papers
ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research
|Quality of Life Research|2013|855
Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate‐to‐severe atopic dermatitis
|British Journal of Dermatology|2019|384
Usability in the real world: assessing medical information technologies in patients’ homes
|Journal of Biomedical Informatics|2003|256
Assessing test–retest reliability of patient-reported outcome measures using intraclass correlation coefficients: recommendations for selecting and documenting the analytical formula
|Quality of Life Research|2018|247
Evaluating patient-perceived control of atopic dermatitis: design, validation, and scoring of the Atopic Dermatitis Control Tool (ADCT)
|Current Medical Research and Opinion|2019|138